Login / Signup

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.

Naoshi SugimotoJunya KandaSou NakamuraToshiyuki KitanoMasakatsu HishizawaTadakazu KondoShin ShimizuAkiko ShigemasaHideyo HiraiYasuyuki AraiManabu MinamiHarue TadaDai MomoseKi-Ryang KohMasayuki NogawaNaohide WatanabeShinichiro OkamotoMakoto HandaAkira SawaguchiNobuki MatsuyamaMitsunobu TanakaTomoya HayashiAkihiro FuchizakiYoshihiko TaniAkifumi Takaori-KondoKoji Eto
Published in: Blood (2022)
Keyphrases
  • clinical trial
  • induced pluripotent stem cells
  • endothelial cells
  • randomized controlled trial
  • open label
  • stem cells
  • study protocol
  • pluripotent stem cells
  • acute kidney injury
  • mesenchymal stem cells